期刊文献+

85例间质性肺疾病临床特征分析 被引量:3

Clinical characteristics of 85 patients with interstitial lung disease
下载PDF
导出
摘要 目的探讨间质性肺疾病临床特点诊断及治疗。方法回顾性分析85例肺间质纤维化患者的临床特点和肺功能及治疗情况。结果两组患者肺功能改变主要为限制性的通气障碍。49例特发性肺间质纤维化(IPF)者,具有进行性呼吸困难和爆裂音杵状指,CT/HRCT表现比较典型。36例继发性肺间质纤维化者伴有原发病症状。结论特发性肺间质纤维化和继发性肺间质纤维化的临床特征各不同,及时诊断对指导治疗及判断疾病进展和预后具有重要意义。 Objective To improve the cognition for the diagnosis, therapy and management of interstitial lung disease (ILD). Methods Retrospective review was conducted of clinical characteristics of 85 patients with ILD in our hospital. Results All the patients had restrictive ventilation dysfunction. Among them, 49 patients with IPF had an insidious onset of progressive dyspnea, cracks and finger clubbing, CT/HRCT examination exhibiting glassy, reticular, stripe and alveolate lesions, and 36 patients with secondary pulmonary fibrosis had symptom of protopathy. Conclusion These clinical characteristics confirm that there are clinical differences between IPF and secondary pulmonary fibrosis. It is useful for treating and predicting procession and long - term survival in the diagnosis of the disease.
出处 《临床肺科杂志》 2009年第2期167-168,共2页 Journal of Clinical Pulmonary Medicine
关键词 间质性肺疾病 肺功能 影像 interstitial lung disease pulmonary function radiography
  • 相关文献

参考文献3

二级参考文献16

  • 1留永健 朱元珏 见:蔡柏蔷 主编.特发性肺纤维化诊断的新进展[A].见:蔡柏蔷,主编.21世纪医师丛书:呼吸内科分册,第1版[C].北京:中国协和医科大学出版社,2000.278-286.
  • 2ATS/ERS. American Thoracic Society/European Respiratory Society international muhidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med, 2002, 165 (2):277-304.
  • 3Chan-Yeung M, Muller NL. Cryptogenic fibrosing alveolitis. Lancet,1997, 350(9078): 651-656.
  • 4Katzenstein ALA, Myers JL. Idiopathic pulmonary fibrosis. Clinical relevance of pathological classification. Am J Respir Crit Care Med,1998, 157(4ptl): 1301-1315.
  • 5Epler GR, Colby TV, McLoud TC, et al. Bronchiolitis obliterans organizing pneumonia. N Engl J Med, 1985, 312(3): 152-158.
  • 6Ryu JH, Colby TV, Hartman TE. Idiopathic pulmonary fibrosis: current concept. Mayo Clin Proc, 1998, 73 (11): 1085-1101.
  • 7Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2001, 164(2): 193-196.
  • 8ATS/ERS. Idiopathic pulmonary fibrosis: diagnosis and treatment international consensus statement. Am J Respir Crit Care Meal, 2000,161 (2pt1): 646-664.
  • 9Daniels CE,whilkes M S, Eens M, et al. lmatinib mesulate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Invest,2004,114(9): 1308-1316.
  • 10Azuma A, Nukiwa T, Tsuboi E,et al. Double blind, placebo- controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2005,171(9): 1040-1047.

共引文献659

同被引文献15

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部